228 related articles for article (PubMed ID: 8465818)
21. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
Whittle JC; Whelton PK; Seidler AJ; Klag MJ
Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
[TBL] [Abstract][Full Text] [Related]
22. Albuminuria and racial disparities in the risk for ESRD.
McClellan WM; Warnock DG; Judd S; Muntner P; Kewalramani R; Cushman M; McClure LA; Newsome BB; Howard G
J Am Soc Nephrol; 2011 Sep; 22(9):1721-8. PubMed ID: 21868498
[TBL] [Abstract][Full Text] [Related]
23. Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy.
Leak TS; Langefeld CD; Keene KL; Gallagher CJ; Lu L; Mychaleckyj JC; Rich SS; Freedman BI; Bowden DW; Sale MM
BMC Med Genet; 2010 Feb; 11():22. PubMed ID: 20144192
[TBL] [Abstract][Full Text] [Related]
24. End-stage renal disease in African-Americans.
Boone CA
Nephrol Nurs J; 2000 Dec; 27(6):597-600. PubMed ID: 16649339
[TBL] [Abstract][Full Text] [Related]
25. Family history of end-stage renal disease does not predict dialytic survival.
Freedman BI; Soucie JM; Kenderes B; Krisher J; Garrett LE; Caruana RJ; McClellan WM
Am J Kidney Dis; 2001 Sep; 38(3):547-52. PubMed ID: 11532687
[TBL] [Abstract][Full Text] [Related]
26. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
[TBL] [Abstract][Full Text] [Related]
27. Family history of end-stage renal disease among incident dialysis patients.
Freedman BI; Soucie JM; McClellan WM
J Am Soc Nephrol; 1997 Dec; 8(12):1942-5. PubMed ID: 9402097
[TBL] [Abstract][Full Text] [Related]
28. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
29. Racial differences in the incidence of end-stage renal disease.
Tell GS; Hylander B; Craven TE; Burkart J
Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
[TBL] [Abstract][Full Text] [Related]
30. Relevance of the ACTN4 gene in African-Americans with non-diabetic end-stage renal disease.
Bostrom MA; Perlegas P; Lu L; Hicks PJ; Hawkins G; Ng MC; Langefeld CD; Freedman BI; Bowden DW
Am J Nephrol; 2012; 36(3):252-60. PubMed ID: 22965004
[TBL] [Abstract][Full Text] [Related]
31. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
Newsome BB; McClellan WM; Allison JJ; Eggers PW; Chen SC; Collins AJ; Kiefe CI; Coffey CS; Warnock DG
Am J Kidney Dis; 2008 Aug; 52(2):251-61. PubMed ID: 18468746
[TBL] [Abstract][Full Text] [Related]
32. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
Hsu CY; Lin F; Vittinghoff E; Shlipak MG
J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100
[TBL] [Abstract][Full Text] [Related]
33. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
Bonomo JA; Ng MC; Palmer ND; Keaton JM; Larsen CP; Hicks PJ; ; Langefeld CD; Freedman BI; Bowden DW
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1434-40. PubMed ID: 24948143
[TBL] [Abstract][Full Text] [Related]
34. HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation.
Freedman BI; Spray BJ; Dunston GM; Heise ER
Am J Kidney Dis; 1994 Jun; 23(6):797-802. PubMed ID: 8203361
[TBL] [Abstract][Full Text] [Related]
35. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis.
Freedman BI; Spray BJ; Heise ER
Am J Kidney Dis; 1994 Mar; 23(3):352-7. PubMed ID: 8128935
[TBL] [Abstract][Full Text] [Related]
36. Racial variation in autosomal dominant polycystic kidney disease.
Freedman BI; Soucie JM; Chapman A; Krisher J; McClellan WM
Am J Kidney Dis; 2000 Jan; 35(1):35-9. PubMed ID: 10620541
[TBL] [Abstract][Full Text] [Related]
37. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
[TBL] [Abstract][Full Text] [Related]
38. A familial risk of chronic renal failure among blacks on dialysis?
Ferguson R; Grim CE; Opgenorth TJ
J Clin Epidemiol; 1988; 41(12):1189-96. PubMed ID: 3210065
[TBL] [Abstract][Full Text] [Related]
39. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease.
Yu H; Bowden DW; Spray BJ; Rich SS; Freedman BI
Hypertension; 1998 Apr; 31(4):906-11. PubMed ID: 9535413
[TBL] [Abstract][Full Text] [Related]
40. Minority advantage in diabetic end-stage renal disease survival on hemodialysis: due to different proportions of diabetic type?
Medina RA; Pugh JA; Monterrosa A; Cornell J
Am J Kidney Dis; 1996 Aug; 28(2):226-34. PubMed ID: 8768918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
